AI Verdict
MDT has stronger fundamentals based on our AI analysis.
MDT vs MRK Fundamental Comparison
| Metric | MDT | MRK |
|---|---|---|
| Revenue | $26.6B | $16.3B |
| Net Income | $3.6B | $-4.2B |
| Net Margin | 13.4% | -26.0% |
| ROE | 7.3% | -9.2% |
| ROA | 3.9% | -3.3% |
| Current Ratio | 2.54x | 1.30x |
| Debt/Equity | 0.57x | 1.02x |
| EPS | $2.76 | $-1.72 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MDT vs MRK: Frequently Asked Questions
Is MDT or MRK a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MDT has stronger fundamentals. MDT is rated BUY (80% confidence) while MRK is rated HOLD (78% confidence). This is not investment advice.
How does MDT compare to MRK fundamentally?
Medtronic plc has ROE of 7.3% vs Merck & Co., Inc.'s -9.2%. Net margins are 13.4% vs -26.0% respectively.
Which stock pays higher dividends, MDT or MRK?
MDT has a dividend yield of N/A or no dividend while MRK has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MDT or MRK for long term?
For long-term investing, consider that MDT has BUY rating with 80% confidence, while MRK has HOLD rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MDT vs MRK?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MDT vs MRK, the AI consensus favors MDT based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.